Indefinite Delivery Contract 75N95022D00022
Award Date
9/28/22
Last Date to Order
9/29/30
Funding Federal Agency
National Institute of Neurological Disorders and Stroke
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
Leidos, Inc.
Ultimate Awardee
Leidos Holdings, Inc.
NAICS Category
541512 - Computer Systems Design Services
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Service Contract Act
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The National Institutes of Health National Institute of Neurological Disorders and Stroke awarded an indefinite-delivery/indefinite-quantity multiple award contract to Battelle Memorial Institute for Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products for Neurological-related Disorders. The original solicitation sought to procure manufacturing and nonclinical services over five years to support the development of biotechnology products for...
The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), has awarded Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned, for-profit manufacturer of goods, an Indefinite Delivery Contract (IDC) valued at $149.2 million. The purpose of this contract is to provide manufacturing and nonclinical studies support for the development of therapeutic biotechnology products for neurological-related disorders. Under this IDC, NINDS...
The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded an indefinite delivery contract to Leidos, Inc. operating as Saic to provide comprehensive and rapid response services supporting research programs. With a potential value of $545,452,906 over seven years ending August 2028, the multiple award contract vehicle enables delivery orders for clinical trials, manufacturing, animal studies, analytics, storage, and basic research. Leidos was issued an...
This federal contract IDV award was issued by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings, Inc. Leidos Biomedical Research Inc. is a Federally Funded Research and Development Center (FFRDC) contractor for the NCI, providing a comprehensive range of biomedical research and facilities support services. The single-award Indefinite Delivery Contract has a potential value...
The federal contract IDV award, with ID HT001122D0028, was issued by the Defense Health Agency, a component of the U.S. Department of Defense, to the prime contractor Leidos, Inc. The contract has a ceiling value of $2,500.00 and an ultimate completion date of June 19, 2032. Leidos, through its Leidos Services Operating Segment division doing business as SAIC, will provide a broad range of medical research and development services to the agency, including areas such as diagnostics, surveillance,...
The federal contract IDV is an Indefinite Delivery Contract (IDC) awarded by the U.S. Navy Bureau of Medicine and Surgery (BUMED) to Leidos, Inc. for $82,065,981.62 over a period ending on September 17, 2025. The contract provides for a wide range of research support services for BUMED, including studies on traumatic brain injury, psychological health, cancer, and rare diseases. Several delivery order contracts have been issued under this IDC, valued at over $66 million in total. These task...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded an Indefinite Delivery Contract to Lovelace Biomedical Research Institute on September 1, 2021 with a potential value of $545,452,906. Under the terms of the contract, Lovelace Biomedical Research Institute will provide a broad range of services to support biomedical research conducted by NIAID, including clinical trials, manufacturing and controls, nonclinical animal studies, analytics,...
The federal contract IDV award to Leidos, Inc. is an Indefinite Delivery Contract with a ceiling value of $0 for "R & D 2007" requirements. The contract was awarded on October 1, 2003 by an unspecified federal agency, with a period of performance through September 30, 2007. As a large, for-profit organization, Leidos, Inc. provides a wide range of professional services to federal government clients, including information technology, engineering, scientific research, and technical...
The National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the Department of Health and Human Services, awarded an Indefinite Delivery Contract (IDC) with a ceiling value of $37,393,571 to Curia Global Inc., doing business as Amri, a leading global contract development and manufacturing organization (CDMO). The IDC, titled the "Drug Manufacturing and Formulation Program (DMFP)," provides a broad range of pharmaceutical research and development...
The National Institutes of Health's National Institute of Neurological Disorders and Stroke (NINDS) has awarded a $750,000 indefinite delivery contract to 10X Genomics, Inc. for the delivery of 10X Genomics optimization slides, reagent kits, and reagent delivery methods. The single-award IDC aims to provide NINDS with 10X Genomics' single-cell analysis tools and services to support the institute's biomedical research into neurological diseases and disorders. Under this contract, NINDS has issued...